- Report
- February 2022
- 272 Pages
Global
From €5557EUR$6,000USD£4,661GBP
- Report
- December 2022
- 437 Pages
Global
From €4874EUR$5,447USD£3,950GBP
- Report
- February 2023
- 96 Pages
Global
From €1800EUR$2,082USD£1,563GBP
- Report
- September 2024
Global
From €300EUR$347USD£260GBP
- Report
- September 2024
Global
From €300EUR$347USD£260GBP
- Report
- June 2022
- 115 Pages
Global
From €1050EUR$1,214USD£912GBP
- Report
- May 2022
- 50 Pages
Global
From €500EUR$578USD£434GBP
- Report
- May 2022
- 32 Pages
Global
From €400EUR$463USD£347GBP
- Report
- September 2024
Global
From €400EUR$463USD£347GBP
- Report
- September 2024
Global
From €300EUR$347USD£260GBP
- Report
- September 2024
Global
From €300EUR$347USD£260GBP
- Report
- September 2024
Global
From €300EUR$347USD£260GBP
- Report
- August 2023
- 267 Pages
Global
From €2150EUR$2,487USD£1,866GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,602USD£1,953GBP
- Report
- September 2023
- 249 Pages
Global
From €4874EUR$5,447USD£3,950GBP
- Report
- June 2022
- 207 Pages
Global
From €4863EUR$5,250USD£4,079GBP
- Report
- June 2024
- 240 Pages
Global
From €472EUR$510USD£396GBP
- Report
- February 2022
- 800 Pages
Global
From €2834EUR$3,060USD£2,377GBP
€3334EUR$3,600USD£2,797GBP
- Report
- June 2023
- 900 Pages
Global
From €2834EUR$3,060USD£2,377GBP
€3334EUR$3,600USD£2,797GBP
- Report
- March 2023
- 300 Pages
Global
From €2204EUR$2,380USD£1,849GBP
€2593EUR$2,800USD£2,175GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more